Literature DB >> 17638123

The kinin antagonist hoe 140 reduces acute paw oedema in rats caused by carrageenan, bradykinin and kaolin.

J N Sharma1, A P Yusof, K J Wirth.   

Abstract

The present study aimed to evaluate the effect of Hoe 140, a BK receptor B(2) antagonist, on acute oedema induced by carrageenan, BK and kaolin in male Wistar Kyoto rats. Hoe 140 (0.2 mg/kg and 20 mg/kg) given ip caused significant (p<0.05 and p<0.01) inhibition of carrageenan and BK-induced paw oedema. This suggests that BK is the prime inflammatory mediator of carrageenan oedema, and that it is also a specific blocker of oedema caused by BK. Furthermore, Hoe 140 was found to be less effective in reducing kaolin-induced oedema in rats. This might reflect that BK is not a prime inflammatory mediator of kaolin-induced oedema. The possible significance of these findings is discussed.

Entities:  

Year:  1998        PMID: 17638123     DOI: 10.1007/s10787-998-0002-8

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  17 in total

Review 1.  The role of the kallikrein-kinin system in joint inflammatory disease.

Authors:  J N Sharma
Journal:  Pharmacol Res       Date:  1991-02       Impact factor: 7.658

Review 2.  The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system.

Authors:  J N Sharma; S S Mohsin
Journal:  Exp Pathol       Date:  1990

3.  Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist.

Authors:  A H Costello; K M Hargreaves
Journal:  Eur J Pharmacol       Date:  1989-11-21       Impact factor: 4.432

4.  Screens for anti-inflammatory drugs.

Authors:  M Di Rosa; D A Willoughby
Journal:  J Pharm Pharmacol       Date:  1971-04       Impact factor: 3.765

5.  Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins.

Authors:  J N Sharma; K J Wirth
Journal:  Gen Pharmacol       Date:  1996-01

6.  Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant.

Authors:  J N Sharma; J N Sharma
Journal:  Arzneimittelforschung       Date:  1977-07

Review 7.  Therapeutic prospects of bradykinin receptor antagonists.

Authors:  J N Sharma
Journal:  Gen Pharmacol       Date:  1993-03

8.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.

Authors:  K Wirth; F J Hock; U Albus; W Linz; H G Alpermann; H Anagnostopoulos; S Henk; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 9.  The role of kinin system in joint inflammatory disease.

Authors:  J N Sharma
Journal:  Eur J Rheumatol Inflamm       Date:  1991

10.  Competitive antagonists of bradykinin.

Authors:  R J Vavrek; J M Stewart
Journal:  Peptides       Date:  1985 Mar-Apr       Impact factor: 3.750

View more
  3 in total

1.  Comparison between plethysmometer and micrometer methods to measure acute paw oedema for screening anti-inflammatory activity in mice.

Authors:  Jagdish N Sharma; Awatef M Samud; M Zaini Asmawi
Journal:  Inflammopharmacology       Date:  2004       Impact factor: 4.473

Review 2.  The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection.

Authors:  Jagdish N Sharma
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy.

Authors:  J N Sharma; A P Yusof
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.